NTI
Click for more information
1.45% 6.8¢ neurotech international limited

Clinical Trial, page-10

  1. rockboy
    2,564 Posts.
    lightbulb Created with Sketch. 223
    clock Created with Sketch.
    22/09/17
    12:00
    Post #: 27393636
    @TraderNin that is a great find, thanks. the more you read this it is clear that for this 5 year old boy Mente Autism has significantly helped and it is his parents who are happy w the progress being made. what better people to judge and assess how effective it has been for their son, they are seeing the progress being made!
    Last edited by rockboy: 22/09/17
    NTI Price at posting: 18.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 3  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Rate cuts, assassination attempts, gold, oil, AI – what to watch in USA this week
right-arrow Created with Sketch.
NEWS Highest-grade niobium assays uncovered at newly acquired Ecuador project – fast-tracking to production
right-arrow Created with Sketch.
NEWS Massive rare earth find near Jupiter project – high ratios of magnet oxides uncovered
right-arrow Created with Sketch.
NEWS Outstanding metallurgical results significantly de-risk Mandilla gold project
right-arrow Created with Sketch.
NEWS HotCopper users bullish on Raiden's news it won Andover South approval as expected
right-arrow Created with Sketch.
NEWS Breakthrough FDA response clears path for OA phase 3 trial – major milestone achieved!
right-arrow Created with Sketch.
watchlist Created with Sketch. Add NTI (ASX) to my watchlist
(20min delay)
Last
6.8¢ 		Change
-0.001(1.45%) 		Mkt cap ! $69.19M
Open High Low Value Volume
6.8¢ 6.8¢ 6.8¢ $1.508K 22.17K

Buyers (Bids)

No. Vol. Price($)
8 301468 6.8¢
 

Sellers (Offers)

Price($) Vol. No.
6.9¢ 26410 1
View Market Depth
Last trade - 13.34pm 18/09/2024 (20 minute delay) ?
NTI (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.